Instrument Business Outlook Volume 34 - Issue 4

6 Jun 2025

Categories:

Instrument Business Outlook

Table of Contents

US Academic Labs Report Steep Cuts to Lab Tool Budgets
- NIH Grant Terminations
- Survey Results
- Conclusion
- Survey Respondents’ Demographics
IBO Sales Indexes Record Positive Results Despite Headwinds
- Analytical Instruments Sales Index
- Life Science Sales Index
- End-Markets
  - Pharmaceutical
  - Academic and Government
  - Industrial
  - Applied
  - Industrial and Applied
- Geography
  - Americas
  - Europe
  - Asia Pacific
  - China
  - Rest of World
- Product Lines
  - Instruments
  - Consumables
  - Services
- Outlook
  - Q2
  - Calendar Year 2025
First Quarter Results: Agilent Technologies, Bio-Techne, Bruker, MilliporeSigma and Revvity
- Agilent Records Mixed But Mostly Positive Results
  - Divisions
  - End-Markets
  - Geography
  - Guidance
- Correction: Agilent Technologies Q1 FY25 Results
- Bio-Techne Predicts Limited Impact from the US Academic Sector
  - Divisions
  - End-Markets
  - Geography
  - Guidance
- Bruker Forecasts Optimism Despite Headwinds
  - Parent Company
  - Bruker Scientific Instruments
  - Guidance
- MilliporeSigma Endures Headwinds from the NIH and China
  - Divisions
  - Geography
  - Guidance
- Revvity Braces for Potential Headwinds
  - Divisions
  - Geography
  - Guidance
Executive Briefing
- Waters Buys Halo Labs
- Antylia Scientific’s Sale Confirmed
- Bruker Invests in Metabolomics
- Higher-Priced Offer for Akoya Withdrawn
- Cell Sorter Technology Acquired
- CST Exits BIOKÉ Distribution
Indexes Post Contrasting Results
- Laboratory Instruments and Products Stock Index
- Diversified Instrumentation Stock Index
- International Stocks
Market Profile: Bead Mill Tissue Homogenizers
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Government and Chemicals: PFAS Changes Put on Hold
- Government and R&D: NIH Grant Withdrawals Multiply
- Biotech: Uncertainty Rises
Region Watch
- UK: Long-term Funding Opportunity Announced
- China: European Pharma Companies’ Pessimism Increases
- Switzerland: Biotech R&D Spending Increases
News
- Broad-Based Companies
- Life Science Instruments
  - Multiomics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
- Chromatography
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Surface Science
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
Bottom Line